702
Views
2
CrossRef citations to date
0
Altmetric
Original Paper

Plasma Norepinephrine and Dopamine Levels in Prepubertal Male Children with Attention-Deficit Hyperactivity Disorder do not Change with 8 Weeks of Methylphenidate Treatment

, MD (Child and Adolescent Psychiatry Specialist) , , , MD (Child and Adolescent Psychiatry Specialist) , , , PHD (Chemist) &
Pages 259-266 | Received 18 Jun 2015, Accepted 02 Aug 2015, Published online: 08 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Esra Cop, Ozgur Oner, Pinar Yurtbasi & Kerim Munir. (2016) Effects of Maternal Symptom Ratings and Other Clinical Features on Short-Term Treatment Response to OROS Methylphenidate in Children and Adolescents with ADHD in a Naturalistic Clinical Setting. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 26:2, pages 126-133.
Read now

Articles from other publishers (1)

Cellina Ching, Guy D. Eslick & Alison S. Poulton. (2019) Evaluation of Methylphenidate Safety and Maximum-Dose Titration Rationale in Attention-Deficit/Hyperactivity Disorder. JAMA Pediatrics 173:7, pages 630.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.